Skip to main content

Astrazeneca PLC 6-K, filed Oct 30, 2026

Astrazeneca PLC (AZN)

6-K 2026-10-30 For: 2026-10-30
View Original
Added on October 30, 2026

About this 6-K

Astrazeneca PLC filed this 6-K on October 30, 2026.

AstraZeneca reported 9M 2026 total revenue up 7% at constant exchange rates and Core EPS up 14%, supported by double-digit growth in Oncology, R&I and Rare Disease. AI summary